CFS Board of Directors Head of School Search Committee Formed gocfs.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gocfs.net Daily Mail and Mail on Sunday newspapers.
DGAP-News: SHS Gesellschaft für Beteiligungsmanagement mbH / Key word(s): Investment/Private Equity
SHS invests in Swiss-German specialty drug company Develco Pharma
17.12.2020 / 09:00
SHS invests in Swiss-German specialty drug company Develco Pharma
Tübingen-based industry investor SHS acquires minority share in formulation specialist Develco Pharma
Develco specializes in the development, approval and production of innovative and generic specialty drugs and offers a unique and broad set of formulation technologies for orally administered medicines with specific substance-release profiles
Develco operates a state-of-the-art production facility of its own in Germany
Equity investment accelerates the development of new medicines
Tübingen, Germany, December 17, 2020
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is investing from its SHS V fund in the Swiss-German specialty drug company Develco Pharma. Founded in 2006 and now with more than 120 employees,
Tübingen-based industry investor SHS acquires minority share in formulation specialist Develco Pharma
Develco specializes in the development, approval and production of innovative and generic specialty drugs and offers a unique and broad set of formulation technologies for orally administered medicines with specific substance-release profiles
Develco operates a state-of-the-art production facility of its own in Germany
Equity investment accelerates the development of new medicines
Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH is investing from its SHS V fund in the Swiss-German specialty drug company Develco Pharma. Founded in 2006 and now with more than 120 employees, the company operates in Switzerland and Schopfheim, Germany, developing and manufacturing orally administered medicines containing known active ingredients in formulations that offer delayed or modified release of active ingredients. Develco has state-of-the-art production operations of its own;